Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
alt text

Download “Practical considerations in transitioning to hybrid or decentralised clinical trials”

The COVID-19 pandemic spurred a greater adoption of both decentralized and hybrid clinical trial models. Will these pandemic-driven changes have a lasting effect on the way trials are run in the future? What does a feasible, robust clinical trial model – one that is both patient-centric and advantageous to the pharma industry – look like?

ICON, in association with Pharmaceutical Contract Management Group (PCMG), recently convened a workshop to explore these questions, and “Practical considerations in transitioning to hybrid or decentralised clinical trials” is the resulting white paper. Access it today for your insights into this critical matter.

alt text

Complete the form to download your free white paper!

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio

By completing this form you agree ICON plc may contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy.